BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 29618078)

  • 1. Simultaneous Time-concentration Analysis of Soman and VX Adducts to Butyrylcholinesterase and Albumin by LC-MS-MS.
    Lee JY; Kim C; Lee YH
    J Anal Toxicol; 2018 Jun; 42(5):293-299. PubMed ID: 29618078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous quantification of soman and VX adducts to butyrylcholinesterase, their aged methylphosphonic acid adduct and butyrylcholinesterase in plasma using an off-column procainamide-gel separation method combined with UHPLC-MS/MS.
    Liu CC; Huang GL; Xi HL; Liu SL; Liu JQ; Yu HL; Zhou SK; Liang LH; Yuan L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Nov; 1036-1037():57-65. PubMed ID: 27718463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Efficiency of Purification (from Human Plasma) of a Nerve Agent Adduct of Butyrylcholinesterase Between the Affinity Gel Method and Immunomagnetic Separation.
    Lee JY
    J Chromatogr Sci; 2018 Mar; 56(3):248-253. PubMed ID: 29244127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of nerve agent adducts with albumin in rat plasma using liquid chromatography-isotope dilution tandem mass spectrometry.
    Bao Y; Liu Q; Chen J; Lin Y; Wu B; Xie J
    J Chromatogr A; 2012 Mar; 1229():164-71. PubMed ID: 22305360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of human butyrylcholinesterase-nerve gas adducts by liquid chromatography-mass spectrometric analysis after in gel chymotryptic digestion.
    Tsuge K; Seto Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jun; 838(1):21-30. PubMed ID: 16569519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generic detection of organophosphorus nerve agent adducts to butyrylcholinesterase in plasma using liquid chromatography-tandem mass spectrometry combined with an improved procainamide-gel separation and pepsin digestion method.
    Liu CC; Liang LH; Yan L; Chen B; Liu XJ; Yang Y; Liu SL; Xi HL
    J Chromatogr A; 2023 May; 1697():463990. PubMed ID: 37075496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modification of human serum albumin by the nerve agent VX: microbore liquid chromatography/electrospray ionization high-resolution time-of-flight tandem mass spectrometry method for detection of phosphonylated tyrosine and novel cysteine containing disulfide adducts.
    Kranawetvogl A; Worek F; Thiermann H; John H
    Rapid Commun Mass Spectrom; 2016 Oct; 30(19):2191-200. PubMed ID: 27490696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conjugates of human serum butyrylcholinesterase and nerve agents are behaviorally safe in rhesus macaques.
    Saxena A; Myers TM; Sipos ML
    Chem Biol Interact; 2021 Aug; 344():109499. PubMed ID: 33961835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioanalytical verification of V-type nerve agent exposure: simultaneous detection of phosphonylated tyrosines and cysteine-containing disulfide-adducts derived from human albumin.
    Kranawetvogl A; Küppers J; Siegert M; Gütschow M; Worek F; Thiermann H; Elsinghorst PW; John H
    Anal Bioanal Chem; 2018 Feb; 410(5):1463-1474. PubMed ID: 29322229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel dual-mode immunomagnetic method for studying reactivation of nerve agent-inhibited butyrylcholinesterase.
    Abney CW; Knaack JL; Ali AA; Johnson RC
    Chem Res Toxicol; 2013 May; 26(5):775-82. PubMed ID: 23656164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous measurement of tabun, sarin, soman, cyclosarin, VR, VX, and VM adducts to tyrosine in blood products by isotope dilution UHPLC-MS/MS.
    Crow BS; Pantazides BG; Quiñones-González J; Garton JW; Carter MD; Perez JW; Watson CM; Tomcik DJ; Crenshaw MD; Brewer BN; Riches JR; Stubbs SJ; Read RW; Evans RA; Thomas JD; Blake TA; Johnson RC
    Anal Chem; 2014 Oct; 86(20):10397-405. PubMed ID: 25286390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Online coupling of immunoextraction, digestion, and microliquid chromatography-tandem mass spectrometry for the analysis of sarin and soman-butyrylcholinesterase adducts in human plasma.
    Bonichon M; Valbi V; Combès A; Desoubries C; Bossée A; Pichon V
    Anal Bioanal Chem; 2018 Jan; 410(3):1039-1051. PubMed ID: 28971225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The stoichiometry of protection against soman and VX toxicity in monkeys pretreated with human butyrylcholinesterase.
    Raveh L; Grauer E; Grunwald J; Cohen E; Ashani Y
    Toxicol Appl Pharmacol; 1997 Jul; 145(1):43-53. PubMed ID: 9221822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small-scale purification of butyrylcholinesterase from human plasma and implementation of a μLC-UV/ESI MS/MS method to detect its organophosphorus adducts.
    John H; Breyer F; Schmidt C; Mizaikoff B; Worek F; Thiermann H
    Drug Test Anal; 2015 Oct; 7(10):947-56. PubMed ID: 25828536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunodetection of serum albumin adducts as biomarkers for organophosphorus exposure.
    Chen S; Zhang J; Lumley L; Cashman JR
    J Pharmacol Exp Ther; 2013 Feb; 344(2):531-41. PubMed ID: 23192655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of administration of human butyrylcholinesterase and its conjugates with soman or VX in rats.
    Genovese RF; Sun W; Johnson CC; Ditargiani RC; Doctor BP; Saxena A
    Basic Clin Pharmacol Toxicol; 2010 May; 106(5):428-34. PubMed ID: 20050840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) for detection and identification of albumin phosphylation by organophosphorus pesticides and G- and V-type nerve agents.
    John H; Breyer F; Thumfart JO; Höchstetter H; Thiermann H
    Anal Bioanal Chem; 2010 Nov; 398(6):2677-91. PubMed ID: 20730528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A high-throughput UHPLC-MS/MS method for the quantification of five aged butyrylcholinesterase biomarkers from human exposure to organophosphorus nerve agents.
    Graham LA; Johnson D; Carter MD; Stout EG; Erol HA; Isenberg SL; Mathews TP; Thomas JD; Johnson RC
    Biomed Chromatogr; 2017 Apr; 31(4):. PubMed ID: 27572107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous quantification of VX and its toxic metabolite in blood and plasma samples and its application for in vivo and in vitro toxicological studies.
    Reiter G; Mikler J; Hill I; Weatherby K; Thiermann H; Worek F
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Sep; 879(26):2704-13. PubMed ID: 21862421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity Based Protein Profiling Leads to Identification of Novel Protein Targets for Nerve Agent VX.
    Carmany D; Walz AJ; Hsu FL; Benton B; Burnett D; Gibbons J; Noort D; Glaros T; Sekowski JW
    Chem Res Toxicol; 2017 Apr; 30(4):1076-1084. PubMed ID: 28267914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.